Oesophageal Cancer Trial, Recruiting NCT06447064 Sponsor: Imperial College London Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT06447064
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years of age or older
  • You must be living in the United Kingdom at the time you sign up for the trial
  • You must be registered with an NHS GP practice
  • You must fall into one of two groups: either you have been diagnosed with one of the following cancers in the last 24 months (bladder, bowel/colorectal, endometrial, liver, oesophageal, ovarian, pancreatic, stomach, uterine, or vulval cancer) — OR — you have not been diagnosed with any type of cancer in the last 6 years (a diagnosis of non-melanoma skin cancer is an exception to this)
  • You must be the named, primary account holder of either a Tesco Clubcard or a Boots Advantage Card, and be willing to share your loyalty card shopping data with the research team
  • You must be willing and able to take part in all required study activities and give written consent to join

Who may not be able to join:

  • People under the age of 18
  • People who are not living in the UK at the time of signing up
  • People who do not hold an eligible Tesco Clubcard or Boots Advantage Card, and have no one in their household who does
  • People who are not the primary named cardholder in their household, if the primary cardholder is either unwilling to also join the study, or does not do shopping on their behalf
  • People wishing to join as a cancer case (Group 1) if their eligible cancer diagnosis was made more than 24 months ago, or if they have also had a different, non-eligible cancer diagnosis within the last 6 years (unless that diagnosis was non-melanoma skin cancer)
  • People wishing to join as a control (Group 2) if they have received any cancer diagnosis in the last 6 years (unless it was non-melanoma skin cancer)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dr James Flanagan, Imperial College London

Phone: 02075942127

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 February 2026
Est. completion
1 February 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Purchase behaviours (purchase of pain relief medications) assessed by Statistical Model

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov